Longitudinal study on the role of body size in premenopausal breast cancer
- PMID: 17130395
- DOI: 10.1001/archinte.166.21.2395
Longitudinal study on the role of body size in premenopausal breast cancer
Abstract
Background: A high body mass index (BMI) has been related to a reduced risk of breast cancer in premenopausal women. The mechanisms underlying this association have not been elucidated.
Methods: We explored whether factors affecting ovulation may explain the inverse association between BMI (calculated as weight in kilograms divided by the square of height in meters) and breast cancer in 113,130 premenopausal participants in the Nurses' Health Study II. During 1,225,520 person-years of prospective follow-up between 1989 and 2003, 1398 incident cases of invasive breast cancer were diagnosed. Weight, height, ovulatory infertility, menstrual cycle patterns, and a multitude of covariates were assessed throughout follow-up. Cox proportional hazards regression was used to compute hazard ratios and 95% confidence intervals (CIs).
Results: We observed a significant linear inverse trend between current BMI and breast cancer incidence (P<.001) that was not explained by menstrual cycle characteristics or infertility due to an ovulatory disorder (covariate-adjusted hazard ratio for breast cancer in women with a BMI > or =30 vs 20.0-22.4, 0.81; 95% CI, 0.68-0.96). We found BMI at age 18 years to be the strongest predictor of breast cancer incidence (covariate-adjusted hazard ratio for breast cancer in women with a BMI at age 18 years > or =27.5 vs 20.0-22.4, 0.57; 95% CI, 0.41-0.81).
Conclusions: Body size during the early phases of adult life seems to be particularly important in the development of premenopausal breast cancer. Factors other than anovulation are likely to mediate the protection conferred by a high BMI.
Similar articles
-
Body fatness throughout the life course and the incidence of premenopausal breast cancer.Int J Epidemiol. 2016 Aug;45(4):1103-1112. doi: 10.1093/ije/dyw149. Epub 2016 Jul 27. Int J Epidemiol. 2016. PMID: 27466312 Free PMC article.
-
A prospective study of breast size and premenopausal breast cancer incidence.Int J Cancer. 2006 Apr 15;118(8):2031-4. doi: 10.1002/ijc.21588. Int J Cancer. 2006. PMID: 16284954
-
Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC).Int J Cancer. 2004 Sep 20;111(5):762-71. doi: 10.1002/ijc.20315. Int J Cancer. 2004. PMID: 15252848
-
A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer.Arch Intern Med. 2006 Dec 11-25;166(22):2484-9. doi: 10.1001/archinte.166.22.2484. Arch Intern Med. 2006. PMID: 17159014
-
The Epidemiological Challenges of Breast Cancer among Premenopausal Women in Limited Resource Settings.Rev Invest Clin. 2017 Mar-Apr;69(2):59-65. doi: 10.24875/ric.17002239. Rev Invest Clin. 2017. PMID: 28453504 Review.
Cited by
-
The impact of obesity and adipokines on breast and gynecologic malignancies.Ann N Y Acad Sci. 2022 Dec;1518(1):131-150. doi: 10.1111/nyas.14916. Epub 2022 Oct 27. Ann N Y Acad Sci. 2022. PMID: 36302117 Free PMC article. Review.
-
Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.Cancer Prev Res (Phila). 2012 Apr;5(4):583-92. doi: 10.1158/1940-6207.CAPR-11-0482. Epub 2012 Feb 7. Cancer Prev Res (Phila). 2012. PMID: 22318751 Free PMC article.
-
Occurrence of breast cancer subtypes in adolescent and young adult women.Breast Cancer Res. 2012 Mar 27;14(2):R55. doi: 10.1186/bcr3156. Breast Cancer Res. 2012. PMID: 22452927 Free PMC article.
-
A case-control study of body mass index and breast cancer risk in white and African-American women.Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1532-44. doi: 10.1158/1055-9965.EPI-10-0025. Epub 2010 May 25. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20501755 Free PMC article.
-
Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.Oncologist. 2017 Dec;22(12):1431-1443. doi: 10.1634/theoncologist.2017-0148. Epub 2017 Sep 14. Oncologist. 2017. PMID: 28912152 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical